Adult intensive care; Cardiovascular system; Drug interactions; Drugs and medicines; Toxicology; Fat Emulsions, Intravenous; prothipendyl; Antipsychotic Agents; Humans; Fat Emulsions, Intravenous/therapeutic use; Medicine (all)
Abstract :
[en] Prothipendyl, a lipophilic neuroleptic drug, requires a careful dosage regimen due to its potential side effects, including life-threatening arrhythmias.This report outlines a case of severe prothipendyl intoxication, its management and the successful utilisation of Intralipid, an intravenous lipid emulsion, in treating ventricular arrhythmia postmassive prothipendyl ingestion. Additionally, the mechanism of action of Intralipid and the rebound concentration of the lipophilic drug in such scenarios are discussed.
Disciplines :
Anesthesia & intensive care
Author, co-author :
Meunier, Anne; Anesthesia and Intensive Care, Montlegia Hospital, Groupe Santé CHC, Liège, Belgium
Goffin, Pierre ; Université de Liège - ULiège > Département des sciences cliniques > Anesthésie et réanimation ; Anesthesia and Intensive Care, Montlegia Hospital, Groupe Santé CHC, Liège, Belgium goffin.pjc@gmail.com
Deville, Marine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de toxicologie clinique, médicolégale, environnementale et en entreprise
Demaret, Pierre; Anesthesia and Intensive Care, Montlegia Hospital, Groupe Santé CHC, Liège, Belgium
Language :
English
Title :
Intravenous lipid emulsion for a life-threatening prothipendyl intoxication.
Krämer M, Broecker S, Madea B, et al. Confirmation of metabolites of the neuroleptic drug prothipendyl using human liver microsomes, specific CYP enzymes and authentic forensic samples-benefit for routine drug testing. J Pharm Biomed Anal 2017; 145: 517-24.
Wu M, Schmitt G, Mattern R. Suicide with prothipendyl. Arch Kriminol 1994; 193: 158-62.
Hefner G, Hahn M, Hiemke C, et al. Pharmacodynamic drug-drug interactions of QT-prolonging drugs in hospitalized psychiatric patients. J Neural Transm (Vienna) 2021; 128: 243-52.
Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 2018; 51: 9-62.
Krämer M, Heese P, Banger M, et al. Range of therapeutic prothipendyl and prothipendyl sulfoxide concentrations in clinical blood samples. Drug Test Anal 2018; 10: 1009-16.
Centre belge D'Information pharmacothérapeutique. n.d. Available: https://www.cbip.be/fr/chapters/11?frag=19992&trade_family=8060. 2018. DOMINAL-Prothipendyl hydrochloride
Hansen EC, Christensen RT, Elley J, et al. Clinical pharmacokinetic studies of perphenazine. Brit J Clinical Pharma 1976; 3: 915-23.
Tampakis K, Vogiatzakis N, Kontogiannis C, et al. Intravenous lipid emulsion as an antidote in clinical toxicology: a systematic review. Eur Rev Med Pharmacol Sci 2020; 24: 7138-48.
Rothschild L, Bern S, Oswald S, et al. Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med 2010; 18: 1-8.
Türkdog an AK, Aköz A, Avcil M, et al. Lipid emulsion therapy in lipophilic or hydrophilic drug intoxication: the last weapon in our arsenal. Eurasian J Emerg Med 2019; 18: 90-4.
Heinonen JA, Litonius E, Backman JT, et al. Intravenous lipid emulsion entraps amitriptyline into plasma and can lower its brain concentration-an experimental intoxication study in pigs. Basic Clin Pharmacol Toxicol 2013; 113: 193-200.
García-Ramos S, Fernandez I, Zaballos M. Emulsiones lipídicas en La Intoxicación Por Anestésicos locales Y Otros Fármacos. Revisión Sobre Mecanismos de Acción Y Recomendaciones de USO. Revista Española de Anestesiología y Reanimación 2022; 69: 421-32.
Sohn JT. The underlying mechanism of lipid emulsion treatment as a nonspecific antidote to drug toxicity. J Emerg Med 2021; 60: e137-8.
Ozcan MS, Weinberg G. Intravenous lipid emulsion for the treatment of drug toxicity. J Intensive Care Med 2014; 29: 59-70.
Cave G, Harvey M, Graudins A. Review article: intravenous lipid emulsion as antidote: a summary of published human experience. Emerg Med Australas 2011; 23: 123-41.
Gosselin S, Hoegberg LCG, Hoffman RS, et al. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning Clin Toxicol (Phila) 2016; 54: 899-923.